Skip to main content
. 2019 Mar 29;2019(3):CD012212. doi: 10.1002/14651858.CD012212.pub2

4.

4

Forest plot of comparison: 1 Supplemental IV crystalloid administration for preventing PONV versus control, outcome: 1.5 Risk of overall PON (when cumulative nausea events were explicitly reported for the entire study period), as measured by the presence of subjective nausea, reported dichotomously or based on a study‐defined dichotomous threshold on a continuous scale such as a VAS.